Melphalan + Bortezomib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Melphalan + Bortezomib, covering 2018-10-12 to 2018-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma [Phase 2]